AMJCtv interviews let you catch up with experts on what's new and important about the changes in healthcare. Where else can a few minutes of your time give you insights from key decision makers - from the clinician, to the health plan leader, to the regulator? AJMCtv interviews give you the close-ups you might not get even if you make it to the conference. When every minute in your day matters, AJMCtv interviews keep you informed.
Karen B. DeSalvo, MD, MPH, MSc, National Coordinator for Health Information Technology said the promise and power of health information technology in the world of public health is vast and growing.
Karen Lewis, MS, MM, CGC, medical policy administrator and genetic counselor at Priority Health, said that providers are engaging in genetic testing, but they are doing so in “an uninformed fashion.”
Peter Paul Yu, MD, FASCO, who this summer became president of the American Society of Clinical Oncology, shared how the group is leading the discussion of what constitutes value in cancer care, as well as the need to engage all stakeholders in this critical topic.
Karen DeSalvo, MD, National Coordinator for Health Information Technology, said that while patients expect their medical records to be confidential, they are open to information sharing so long as it leads to improvements in their health or the health of others. Moreover, as Dr DeSalvo reveals, many patients expect their medical records to be digitized.
Len Nichols, PhD, director of the Center for Health Policy Research and Ethics (CHPRE) and a professor of Health Policy at George Mason University, describes how medical tourism improves care while lowering costs.
Richard Umdenstock, president and chief executive officer, American Hospital Association, says that many Americans who are newly insured have not had a high level of interaction with the healthcare system. Some people in this patient population might not even know that there are opportunities to engage with members in their community.
Jan Berger, MD, MJ, President & CEO, Health Intelligence Partners, and editor-in-chief of The American Journal of Pharmacy Benefits, explains that next generation sequencing involves gaining a better understanding and deeper knowledge of the subject, not just another “test here or a test there.”
Amy Berman, BS, RN, senior program officer at the John A. Hartford Foundation, says that the triple aim promotes better health, better care, and lower costs. All too often, however, current oncology treatment regimens do not achieve the triple aim.